{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T02:28:55Z","timestamp":1786328935948,"version":"build-2736575974"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Heart Fail Rev"],"DOI":"10.1007\/s10741-026-10665-9","type":"journal-article","created":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T01:51:20Z","timestamp":1786326680000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The role of IL-6 in hypertrophic and dilated cardiomyopathy: clinical and therapeutic implications"],"prefix":"10.1007","volume":"31","author":[{"given":"Lydia","family":"Krexi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitra","family":"Krexi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy Rider","family":"Betts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,10]]},"reference":[{"issue":"806","key":"10665_CR1","doi-asserted-by":"publisher","first-page":"eadq3516","DOI":"10.1126\/scitranslmed.adq3516","volume":"17","author":"YJ Wang","year":"2025","unstructured":"Wang YJ et al (2025) Regulatory T cells attenuate chronic inflammation and cardiac fibrosis in hypertrophic cardiomyopathy. Sci Transl Med 17(806):eadq3516","journal-title":"Sci Transl Med"},{"issue":"1","key":"10665_CR2","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/s41572-019-0084-1","volume":"5","author":"HP Schultheiss","year":"2019","unstructured":"Schultheiss HP et al (2019) Dilated cardiomyopathy. Nat Rev Dis Primers 5(1):32","journal-title":"Nat Rev Dis Primers"},{"issue":"39","key":"10665_CR3","doi-asserted-by":"publisher","first-page":"2733","DOI":"10.1093\/eurheartj\/ehu284","volume":"35","author":"AT Force","year":"2014","unstructured":"Force AT (2014) 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J 35(39):2733\u20132779","journal-title":"Eur Heart J"},{"issue":"Pt 1","key":"10665_CR4","first-page":"1","volume":"374","author":"PC Heinrich","year":"2003","unstructured":"Heinrich PC et al (2003) Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem J 374(Pt 1):1\u201320","journal-title":"Biochem J"},{"issue":"11","key":"10665_CR5","first-page":"5063","volume":"9","author":"L Fang","year":"2017","unstructured":"Fang L et al (2017) Systemic inflammation is associated with myocardial fibrosis, diastolic dysfunction, and cardiac hypertrophy in patients with hypertrophic cardiomyopathy. Am J Transl Res 9(11):5063\u20135073","journal-title":"Am J Transl Res"},{"issue":"9","key":"10665_CR6","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/S0002-9149(97)89206-5","volume":"77","author":"MA Munger","year":"1996","unstructured":"Munger MA et al (1996) Circulating concentrations of proinflammatory cytokines in mild or moderate heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 77(9):723\u2013727","journal-title":"Am J Cardiol"},{"issue":"2","key":"10665_CR7","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.amjcard.2004.03.078","volume":"94","author":"M Hogye","year":"2004","unstructured":"Hogye M et al (2004) Comparison of circulating levels of interleukin-6 and tumor necrosis factor-alpha in hypertrophic cardiomyopathy and in idiopathic dilated cardiomyopathy. Am J Cardiol 94(2):249\u2013251","journal-title":"Am J Cardiol"},{"issue":"2","key":"10665_CR8","doi-asserted-by":"publisher","first-page":"132","DOI":"10.15171\/jcvtr.2019.23","volume":"11","author":"M Iravani Saadi","year":"2019","unstructured":"Iravani Saadi M et al (2019) The circulating level of interleukins 6 and 18 in ischemic and idiopathic dilated cardiomyopathy. J Cardiovasc Thorac Res 11(2):132\u2013137","journal-title":"J Cardiovasc Thorac Res"},{"key":"10665_CR9","doi-asserted-by":"crossref","unstructured":"Kazukauskiene I et al (2021) Inflammation-related biomarkers are associated with heart failure severity and poor clinical outcomes in patients with non-ischemic dilated cardiomyopathy. Life (Basel), 11(10)","DOI":"10.3390\/life11101006"},{"issue":"6","key":"10665_CR10","doi-asserted-by":"publisher","first-page":"791","DOI":"10.3346\/jkms.2003.18.6.791","volume":"18","author":"HJ Chang","year":"2003","unstructured":"Chang HJ et al (2003) The origin of proinflammatory cytokines in patients with idiopathic dilated cardiomyopathy. J Korean Med Sci 18(6):791\u2013796","journal-title":"J Korean Med Sci"},{"issue":"7","key":"10665_CR11","first-page":"3042","volume":"23","author":"Q Li","year":"2019","unstructured":"Li Q et al (2019) Effect of IL-6-mediated STAT3 signaling pathway on myocardial apoptosis in mice with dilated cardiomyopathy. Eur Rev Med Pharmacol Sci 23(7):3042\u20133050","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"1","key":"10665_CR12","first-page":"53","volume":"15","author":"K Buzas","year":"2004","unstructured":"Buzas K et al (2004) Comparative study of the roles of cytokines and apoptosis in dilated and hypertrophic cardiomyopathies. Eur Cytokine Netw 15(1):53\u201359","journal-title":"Eur Cytokine Netw"},{"issue":"5","key":"10665_CR13","doi-asserted-by":"publisher","first-page":"407","DOI":"10.5144\/0256-4947.2014.407","volume":"34","author":"A Liaquat","year":"2014","unstructured":"Liaquat A et al (2014) Polymorphisms of tumor necrosis factor-alpha and interleukin-6 gene and C-reactive protein profiles in patients with idiopathic dilated cardiomyopathy. Ann Saudi Med 34(5):407\u2013414","journal-title":"Ann Saudi Med"},{"issue":"1","key":"10665_CR14","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.cyto.2011.01.004","volume":"54","author":"S Adamopoulos","year":"2011","unstructured":"Adamopoulos S et al (2011) Cytokine gene polymorphisms are associated with markers of disease severity and prognosis in patients with idiopathic dilated cardiomyopathy. Cytokine 54(1):68\u201373","journal-title":"Cytokine"},{"issue":"4","key":"10665_CR15","doi-asserted-by":"publisher","first-page":"61","DOI":"10.14715\/cmb\/2024.70.4.10","volume":"70","author":"N Liu","year":"2024","unstructured":"Liu N et al (2024) Correlations of IL-1 and IL-6 Gene polymorphisms with hypertrophic cardiomyopathy. Cell Mol Biol (Noisy-le-grand) 70(4):61\u201367","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"issue":"7","key":"10665_CR16","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1161\/01.CIR.0000084539.58092.DE","volume":"108","author":"K Node","year":"2003","unstructured":"Node K et al (2003) Short-term statin therapy improves cardiac function and symptoms in patients with idiopathic dilated cardiomyopathy. Circulation 108(7):839\u2013843","journal-title":"Circulation"},{"issue":"12","key":"10665_CR17","first-page":"MS12","volume":"15","author":"A Bielecka-Dabrowa","year":"2009","unstructured":"Bielecka-Dabrowa A et al (2009) The influence of atorvastatin on parameters of inflammation and function of the left ventricle in patients with dilated cardiomyopathy. Med Sci Monit 15(12):MS12\u201323","journal-title":"Med Sci Monit"},{"key":"10665_CR18","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/1476-511X-9-21","volume":"9","author":"A Bielecka-Dabrowa","year":"2010","unstructured":"Bielecka-Dabrowa A et al (2010) Influence of co-existing atrial fibrillation on the efficacy of atorvastatin treatment in patients with dilated cardiomyopathy: a pilot study. Lipids Health Dis 9:21","journal-title":"Lipids Health Dis"},{"issue":"2","key":"10665_CR19","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.ejheart.2003.09.005","volume":"6","author":"P Bahrmann","year":"2004","unstructured":"Bahrmann P et al (2004) Pentoxifylline in ischemic, hypertensive and idiopathic-dilated cardiomyopathy: effects on left-ventricular function, inflammatory cytokines and symptoms. Eur J Heart Fail 6(2):195\u2013201","journal-title":"Eur J Heart Fail"},{"issue":"24","key":"10665_CR20","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1016\/S0195-668X(03)00480-9","volume":"24","author":"S Adamopoulos","year":"2003","unstructured":"Adamopoulos S et al (2003) Effects of growth hormone on circulating cytokine network, and left ventricular contractile performance and geometry in patients with idiopathic dilated cardiomyopathy. Eur Heart J 24(24):2186\u20132196","journal-title":"Eur Heart J"},{"issue":"2","key":"10665_CR21","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1067\/mhj.2002.124052","volume":"144","author":"S Adamopoulos","year":"2002","unstructured":"Adamopoulos S et al (2002) Growth hormone administration reduces circulating proinflammatory cytokines and soluble Fas\/soluble Fas ligand system in patients with chronic heart failure secondary to idiopathic dilated cardiomyopathy. Am Heart J 144(2):359\u2013364","journal-title":"Am Heart J"},{"key":"10665_CR22","doi-asserted-by":"publisher","first-page":"1470488","DOI":"10.3389\/fimmu.2025.1470488","volume":"16","author":"S Parisi","year":"2025","unstructured":"Parisi S et al (2025) Update on tocilizumab in rheumatoid arthritis: a narrative review. Front Immunol 16:1470488","journal-title":"Front Immunol"},{"issue":"6","key":"10665_CR23","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s00395-014-0449-2","volume":"109","author":"K Savvatis","year":"2014","unstructured":"Savvatis K et al (2014) Interleukin-6 receptor inhibition modulates the immune reaction and restores titin phosphorylation in experimental myocarditis. Basic Res Cardiol 109(6):449","journal-title":"Basic Res Cardiol"}],"container-title":["Heart Failure Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-026-10665-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10741-026-10665-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-026-10665-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T01:51:22Z","timestamp":1786326682000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10741-026-10665-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,10]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["10665"],"URL":"https:\/\/doi.org\/10.1007\/s10741-026-10665-9","relation":{},"ISSN":["1573-7322"],"issn-type":[{"value":"1573-7322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,10]]},"assertion":[{"value":"25 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing intersts","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"93"}}